Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

NCT00039429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

NETWORK

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: atrasentan hydrochloride

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]